233 related articles for article (PubMed ID: 30560912)
21. Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma.
Kim JH; Shin SJ; Heo SJ; Choe EA; Kim CG; Jung M; Keum KC; Yoon JS; Lee SC; Shin SJ
Cancer Res Treat; 2018 Oct; 50(4):1238-1251. PubMed ID: 29281872
[TBL] [Abstract][Full Text] [Related]
22. Radiologic and Histopathologic Correlation of Different Growth Patterns of Metastatic Uveal Melanoma to the Liver.
Liao A; Mittal P; Lawson DH; Yang JJ; Szalai E; Grossniklaus HE
Ophthalmology; 2018 Apr; 125(4):597-605. PubMed ID: 29122287
[TBL] [Abstract][Full Text] [Related]
23. The treatment of metastatic uveal melanoma.
Pyrhönen S
Eur J Cancer; 1998 Jul; 34 Suppl 3():S27-30. PubMed ID: 9849406
[TBL] [Abstract][Full Text] [Related]
24. Uveal melanoma: physiopathology and new in situ-specific therapies.
Souto EB; Zielinska A; Luis M; Carbone C; Martins-Gomes C; Souto SB; Silva AM
Cancer Chemother Pharmacol; 2019 Jul; 84(1):15-32. PubMed ID: 31079217
[TBL] [Abstract][Full Text] [Related]
25. Treatment of liver metastases from uveal melanoma: a retrospective single-center analysis.
Yang XY; Xie F; Tao R; Li AJ; Wu MC
Hepatobiliary Pancreat Dis Int; 2013 Dec; 12(6):602-6. PubMed ID: 24322745
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous melanoma metastatic to the eyelid and periocular skin.
Ramirez R; Ivan D; Prieto VG; Hayek B; Diwan H; Savar A; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2010; 26(2):88-94. PubMed ID: 20305506
[TBL] [Abstract][Full Text] [Related]
27. Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.
Kuk D; Shoushtari AN; Barker CA; Panageas KS; Munhoz RR; Momtaz P; Ariyan CE; Brady MS; Coit DG; Bogatch K; Callahan MK; Wolchok JD; Carvajal RD; Postow MA
Oncologist; 2016 Jul; 21(7):848-54. PubMed ID: 27286787
[TBL] [Abstract][Full Text] [Related]
28. Clinical Course of a Presumed Metastatic Uveal Melanoma to the Contralateral Choroid.
Caminal Mitjana JM; Vilà Grané N; Adán Civera A; Sabater N; Arias Barquet L; Rubio Caso MJ
Semin Ophthalmol; 2015; 30(5-6):417-9. PubMed ID: 24171794
[TBL] [Abstract][Full Text] [Related]
29. Uveal melanoma: relatively rare but deadly cancer.
Kaliki S; Shields CL
Eye (Lond); 2017 Feb; 31(2):241-257. PubMed ID: 27911450
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors of liver metastases from uveal melanoma.
Kodjikian L; Grange JD; Baldo S; Baillif S; Garweg JG; Rivoire M
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):985-93. PubMed ID: 15891893
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous malignant melanoma metastatic to the eyelid.
Hartstein ME; Biesman B; Kincaid MC
Ophthalmic Surg Lasers; 1998 Dec; 29(12):993-5. PubMed ID: 9854711
[TBL] [Abstract][Full Text] [Related]
32. Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma.
Choudhary MM; Gupta A; Bena J; Emch T; Singh AD
JAMA Ophthalmol; 2016 Feb; 134(2):174-80. PubMed ID: 26633182
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic signaling in uveal melanoma.
Park JJ; Diefenbach RJ; Joshua AM; Kefford RF; Carlino MS; Rizos H
Pigment Cell Melanoma Res; 2018 Nov; 31(6):661-672. PubMed ID: 29738114
[TBL] [Abstract][Full Text] [Related]
34. Multinodular goiter and primary hyperparathyroidism: a circuitous route to diagnosing metastatic uveal melanoma.
Theoharis CG; Carling T; Buza N; Zambrano E; Sosa JA
Endocr Pathol; 2008; 19(4):294-8. PubMed ID: 18758693
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous malignant melanoma metastatic to the eye, lids, and orbit.
Rosenberg C; Finger PT
Surv Ophthalmol; 2008; 53(3):187-202. PubMed ID: 18501266
[TBL] [Abstract][Full Text] [Related]
36. Association of TYRP1 with hypoxia and its correlation with patient outcome in uveal melanoma.
Jha J; Singh MK; Singh L; Pushker N; Lomi N; Meel R; Chosdol K; Sen S; Bakhshi S; Kashyap S
Clin Transl Oncol; 2021 Sep; 23(9):1874-1884. PubMed ID: 33811629
[TBL] [Abstract][Full Text] [Related]
37. Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis.
Pan H; Lu L; Cui J; Yang Y; Wang Z; Fan X
Aging (Albany NY); 2020 Jan; 12(2):1446-1464. PubMed ID: 31954372
[TBL] [Abstract][Full Text] [Related]
38. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
[TBL] [Abstract][Full Text] [Related]
39. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
40. Metastatic uveal melanoma.
Singh AD; Borden EC
Ophthalmol Clin North Am; 2005 Mar; 18(1):143-50, ix. PubMed ID: 15763199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
